Anticoagulation strategy and safety in critically ill COVID-19 patients: a French retrospective multicentre study

被引:0
作者
Pauline Lamouche-Wilquin
Léa Perrin
Morgane Pere
Matthieu Raymond
Pierre Asfar
Cedric Darreau
Florian Reizine
Gwenhaël Colin
Agathe Delbove
Johann Auchabie
Baptiste Hourmant
Aurélien Frérou
Béatrice La Combe
Jean Morin
Pierre Kergoat
Julien Lorber
Pierre-Yves Egreteau
Jérome Souchard
Emmanuel Canet
Jean-Baptiste Lascarrou
机构
[1] Centre Hospitalier Universitaire de Nantes,Service de Médecine Intensive Réanimation
[2] Centre Hospitalier de Saint-Nazaire,Service de Médecine Intensive Réanimation
[3] Centre Hospitalier Universitaire de Nantes,Plateforme de Méthodologie et Biostatistique
[4] Centre Hospitalier Universitaire d’Angers,Service de Médecine Intensive Réanimation
[5] Centre Hospitalier Le Mans,Service de Médecine Intensive Réanimation
[6] Centre Hospitalier Universitaire de Rennes,Service de Médecine Intensive Réanimation
[7] Centre Hospitalier Départemental de Vendée,Service de Médecine Intensive Réanimation
[8] Centre Hospitalier Bretagne Atlantique,Service de Réanimation Polyvalente
[9] Centre Hospitalier de Cholet,Service de Réanimation Polyvalente
[10] Centre Hospitalier Universitaire de Brest,Service de Médecine Intensive Réanimation
[11] Centre Hospitalier de Saint-Malo,Service de Réanimation Polyvalente
[12] Centre Hospitalier Bretagne Sud,Service de Réanimation Polyvalente
[13] Centre Hospitalier Universitaire de Nantes,Service de Soins Intensifs de Pneumologie
[14] Centre Hospitalier de Cornouaille,Service de Réanimation Polyvalente
[15] Centre Hospitalier de Morlaix,Service de Réanimation Polyvalente
[16] Centre Hospitalier Universitaire de Rennes,Service de Réanimation Chirurgicale
来源
Thrombosis Journal | / 21卷
关键词
COVID-19; Anticoagulation strategies; Venous thromboembolism; Deep vein thrombosis; Pulmonary embolism; Intensive care unit;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 154 条
[1]  
Chen N(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet Lond Engl 15 févr 395 507-13
[2]  
Zhou M(2020)Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet Lond Engl 15 févr 395 497-506
[3]  
Dong X(2020)Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia J Thromb Haemost JTH avr 18 844-7
[4]  
Qu J(2020)High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients J Thromb Haemost 18 1743-6
[5]  
Gong F(2020)Inadequate prophylactic effect of low-molecular weight heparin in critically ill COVID-19 patients J Crit Care 1 déc 60 249-52
[6]  
Han Y(2020)Factors Associated with Pulmonary Embolism among Coronavirus Disease 2019 Acute Respiratory Distress Syndrome: a Multicenter Study among 375 patients Crit Care Explor 2 e0166-88
[7]  
Huang C(2020)Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis Thromb J 23 nov 18 34-9
[8]  
Wang Y(2020)Pathophysiological processes underlying the high prevalence of deep vein thrombosis in critically ill COVID-19 patients Front Physiol 11 608788-e226S
[9]  
Li X(2020)Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring Crit Care 19 juin 24 364-83
[10]  
Ren L(2021)American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19 Blood Adv 9 févr 5 872-5